IT1396920B1 - FORMULATIONS INCLUDING CARNOSIS ACID, OR EXTRACTIVE DERIVATIVES THAT CONTAIN IT, FOR THE TREATMENT AND PREVENTION OF HYPERTRIGLICERIDEMIA - Google Patents
FORMULATIONS INCLUDING CARNOSIS ACID, OR EXTRACTIVE DERIVATIVES THAT CONTAIN IT, FOR THE TREATMENT AND PREVENTION OF HYPERTRIGLICERIDEMIAInfo
- Publication number
- IT1396920B1 IT1396920B1 ITMI2009A001970A ITMI20091970A IT1396920B1 IT 1396920 B1 IT1396920 B1 IT 1396920B1 IT MI2009A001970 A ITMI2009A001970 A IT MI2009A001970A IT MI20091970 A ITMI20091970 A IT MI20091970A IT 1396920 B1 IT1396920 B1 IT 1396920B1
- Authority
- IT
- Italy
- Prior art keywords
- carnosis
- hypertrigliceridemia
- extractive
- prevention
- derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2009A001970A IT1396920B1 (en) | 2009-11-11 | 2009-11-11 | FORMULATIONS INCLUDING CARNOSIS ACID, OR EXTRACTIVE DERIVATIVES THAT CONTAIN IT, FOR THE TREATMENT AND PREVENTION OF HYPERTRIGLICERIDEMIA |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2009A001970A IT1396920B1 (en) | 2009-11-11 | 2009-11-11 | FORMULATIONS INCLUDING CARNOSIS ACID, OR EXTRACTIVE DERIVATIVES THAT CONTAIN IT, FOR THE TREATMENT AND PREVENTION OF HYPERTRIGLICERIDEMIA |
Publications (2)
Publication Number | Publication Date |
---|---|
ITMI20091970A1 ITMI20091970A1 (en) | 2011-05-12 |
IT1396920B1 true IT1396920B1 (en) | 2012-12-20 |
Family
ID=42269546
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITMI2009A001970A IT1396920B1 (en) | 2009-11-11 | 2009-11-11 | FORMULATIONS INCLUDING CARNOSIS ACID, OR EXTRACTIVE DERIVATIVES THAT CONTAIN IT, FOR THE TREATMENT AND PREVENTION OF HYPERTRIGLICERIDEMIA |
Country Status (1)
Country | Link |
---|---|
IT (1) | IT1396920B1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3980952B2 (en) * | 2002-04-12 | 2007-09-26 | 森下仁丹株式会社 | Enteric fat absorption inhibitor containing plant extract and food containing the same |
IL173971A (en) * | 2006-02-27 | 2012-07-31 | Lycored Ltd | Compositions for treating age-related macular degeneration |
EP1925302A1 (en) * | 2006-11-24 | 2008-05-28 | DSMIP Assets B.V. | Dietary or pharmaceutical compositions containing tricyclic diterpenes and derivatives thereof for the treatment of depression |
WO2009154396A2 (en) * | 2008-06-17 | 2009-12-23 | Pharmapex Co., Ltd. | Sustained releasing preparation comprising a crude drug extract for preventing moisturization and controlled release |
-
2009
- 2009-11-11 IT ITMI2009A001970A patent/IT1396920B1/en active
Also Published As
Publication number | Publication date |
---|---|
ITMI20091970A1 (en) | 2011-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SMT201600055B (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF GLAUCOMA | |
CL2013003372A1 (en) | Compounds derived from spiro- [1,3] -oxacins and spiro- [1,4] -oxacepins, inhibitors of bace1 and / or bace2; pharmaceutical composition; procedure to prepare them; and its use in the treatment and / or prophylaxis of Alzheimer's disease and diabetes. | |
CL2013001654A1 (en) | Compounds derived from 6-amino-2-phenylamino-1h-benzimidazol-5-carboxamide; pharmaceutical composition; and its use in the treatment and / or prevention of inflammatory diseases and / or associated conditions, in particular pain. | |
DK2504005T3 (en) | USE OF 1,3-DIPHENYLPROP-2-ONE-1-DERIVATIVES FOR THE TREATMENT OF LIVER DISEASES | |
BR112013015855A2 (en) | compound, use of a compound, methods of prevention, treatment, amelioration or prophylaxis of physiological disorders or diseases, and treatment or amelioration of cosmetic indications; and, pharmaceutical composition. | |
BR112012016733A2 (en) | "compound, fungicidal composition and method" | |
EA201190217A1 (en) | SUBSTITUTED 2-ACETAMIDO-5-ARIL-1,2,4-TRIAZOLONES AND THEIR APPLICATION | |
DK1937633T3 (en) | Biphenyloxyacetic acid derivatives for the treatment of respiratory diseases | |
IL211825A (en) | Pyridine and pyrimidine based compounds for use as wnt signaling pathway inhibitors, pharmaceutical formulations comprising such compounds and use thereof as medicaments for the treatment and/or prophylaxis of cancer | |
WO2011077043A3 (en) | Phenol derivatives and pharmaceutical or cosmetic use thereof | |
ITMI20072416A1 (en) | POLYSACCHARIDIC DERIVATIVES OF LIPOIC ACID, THEIR PREPARATION AND USE AS DERMOCOSMETICS AND MEDICAL PRESIDES | |
ITTO20110630A1 (en) | PHARMACEUTICAL COMPOSITIONS OF COMBINATION AND METHOD FOR TREATING VERTEINS, KINETOSIS AND VEGETATIVE VASCULAR DISTONIA | |
IT1402018B1 (en) | FORMULATIONS FOR THE TREATMENT OF THE AFFECTIONS OF THE FIRST RESPIRATORY ROUTES. | |
IL223289A (en) | Triazine derivatives and pharmaceutical compositions comprising them for the treatment of type 2 diabetes | |
WO2012037562A3 (en) | Pharmaceutical and nutraceutical compositions of abscisic acid | |
IT1391866B1 (en) | INJECTIONABLE COMPOSITION OF POLYNUCLEOTIDS FOR THE TREATMENT OF OSTEOARTICULAR DISEASES. | |
IL199829A0 (en) | Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome | |
SMT201500124B (en) | Compositions of bisphosphonates and methods for the treatment of heart failure | |
CL2014003325A1 (en) | Compounds derived from difluoro-hexahydro-cyclopentaoxacinyls and difluoro-hexahydro-benzooxacinyls, bace 1 inhibitors; pharmaceutical composition; and its use in the treatment of diseases with elevated levels of beta-amyloid, such as Alzheimer's disease | |
EP2249823A4 (en) | Octanoic acid formulations and methods of treatment using the same | |
FI20095600A (en) | Composition for the treatment of skin diseases | |
CL2014003607A1 (en) | Compounds derived from benzodioxol, acetylcholinesterase inhibitors; Preparation method; intermediary compounds; pharmaceutical composition; and use in the prevention or treatment of Alzheimer's disease. | |
EE201300004A (en) | A combined pharmaceutical composition for the treatment of diseases or conditions of the cardiovascular system | |
IT1397838B1 (en) | COMPOSITION FOR TREATMENT OF PLANTS | |
DK2361627T3 (en) | Composition for the prevention or treatment of eye diseases |